Needham analyst Michael Matson maintained a Hold rating on Boston Scientific (BSX – Research Report) today. The company's shares closed last Wednesday at $43.10. According to TipRanks.com, Matson is a 4-star analyst with an average return of 5.0% and a 51.1% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Cardiovascular Systems. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Boston Scientific with a $50.17 average price target, a 15.2% upside from current levels.
https://www.tipranks.com/news/blurbs/needham-keeps-their-hold-rating-on-boston-scientific-bsx?utm_source=advfn.com&utm_medium=referral
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Boston Scientific Charts.